Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Financial Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
TESLA, INC.
APPLE INC.
AMAZON.COM, INC.
META PLATFORMS, INC.
NVIDIA CORPORATION
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
World Press Review
Pump & Dump
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
All our stock picks
North America
Europe
Asia
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Yield stocks
Trend-Following Stocks
Momentum stocks
ESG stocks
Growth stocks
Undervalued stocks
Investment Themes
Homepage
Biotechnology
Sin stocks
Hydrogen
Artificial Intelligence
Fintechs
Cybersecurity
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
In Vino Veritas
The Vegan Market
Fintechs
Europe's family businesses
Let's all cycle!
Education
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
Switzerland
Swiss Exchange
IGEA Pharma N.V.
News
Summary
IGPH
NL0012768675
IGEA PHARMA N.V.
(IGPH)
Add to my list
Report
Delayed Swiss Exchange -
12:30:21 2023-03-24 pm EDT
0.0120
CHF
+9.09%
03/13
Igea Pharma N : Convening notice & Agenda
PU
2022
Igea Pharma N : appoints new Chief Financial Officer
PU
2022
Igea Pharma N : Minutes of the AGM 1 December 2022
PU
Summary
Quotes
Charts
News
Calendar
Company
Financials
Funds
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about IGEA PHARMA N.V.
03/13
Igea Pharma N : Convening notice & Agenda
PU
2022
Igea Pharma N : appoints new Chief Financial Officer
PU
2022
Igea Pharma N : Minutes of the AGM 1 December 2022
PU
2022
Igea Pharma N : announces annual General Meeting Resolutions
PU
2022
IGEA Pharma's H1 Loss Shrinks Amid Lower Expenses
MT
2022
Igea Pharma N.v. : Igea discloses its 2022 Half-Year Financial Report
EQ
2022
IGEA Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022
Igea Pharma N.v. : Igea discloses its 2021 annual report
EQ
2022
Igea Pharma N : Convening Notice and Agenda
PU
2022
IGEA Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2022
Igea Pharma N.v. : IGEA to get SIX approval to the semi-annual 2022 report disclosure
EQ
2022
Igea Pharma N : to get SIX approval to the semi-annual 2022 report disclosure
PU
2022
Swiss Exchange Regulator Investigates IGEA Pharma For Violating Reporting Rules
MT
2022
Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022
Igea Pharma N : to get SIX further approval to the 2021 annual report disclosure
PU
More most relevant news
All news about IGEA PHARMA N.V.
03/13
Igea Pharma N : Convening notice & Agenda
PU
2022
Igea Pharma N : appoints new Chief Financial Officer
PU
2022
Igea Pharma N : Minutes of the AGM 1 December 2022
PU
2022
Igea Pharma N : announces annual General Meeting Resolutions
PU
2022
IGEA Pharma's H1 Loss Shrinks Amid Lower Expenses
MT
2022
Igea Pharma N.v. : Igea discloses its 2022 Half-Year Financial Report
EQ
2022
IGEA Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022
Igea Pharma N.v. : Igea discloses its 2021 annual report
EQ
2022
Igea Pharma N : Convening Notice and Agenda
PU
2022
IGEA Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
More news
News in other languages on IGEA PHARMA N.V.
2022
La perte d'IGEA Pharma au premier semestre se réduit en raison de la baisse des dépense..
2022
Igea Pharma: liquidités suffisantes pour 12 mois après une perte au 1er seme..
2022
Igea Pharma verfügt nach Verlust im H1 über ausreichend Mittel für 12 Monate
2022
IGEA Pharma N.V. annonce ses résultats pour le semestre clos le 30 juin 2022
2022
IGEA Pharma dürfen Handel gemäss SIX wieder aufnehmen
2022
Igea Pharma: fin de la suspension de la cotation sur SIX
2022
IGEA publie son rapport annuel avec six mois de retard
2022
IGEA veröffentlicht Jahresbericht 2021 mit halbem Jahr Verspätung
2022
IGEA Pharma N.V. annonce ses résultats pour l'année complète se terminant le 31 décembr..
2022
Igea attend de livrer son rapport 2021 avant de publier le 1er semestre 2022
More news
Press releases
03/13
Igea Pharma N : Convening notice & Agenda
PU
2022
Igea Pharma N : appoints new Chief Financial Officer
PU
2022
Igea Pharma N : Minutes of the AGM 1 December 2022
PU
2022
Igea Pharma N : announces annual General Meeting Resolutions
PU
2022
Igea Pharma N.v. : Igea discloses its 2022 Half-Year Financial Report
EQ
More press releases
Upcoming event on IGEA PHARMA N.V.
04/28/23
FY 2022 Earnings Release
Company calendar
Upcoming sector events
04/07/23
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. : FY 2022 Earnings Release
04/25/23
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. : Q1 2023 Earnings Release (Projected)
05/03/23
10X GENOMICS, INC. : Q1 2023 Earnings Release (Projected)
05/04/23
NATERA, INC. : Q1 2023 Earnings Release (Projected)
More events
Sector
Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances
MarketScreener: Created by Investors for Investors!
100% Free Registration
Slave